XNYS
RNR
Market cap12bUSD
Jun 17, Last price
303.02USD
1D
0.80%
1Q
3.89%
Jan 2017
122.45%
Name
Renaissancere Holdings Ltd
Chart & Performance
P/E
6.91
P/S
1.11
EPS
43.87
Div Yield, %
0.53%
Shrs. gr., 5y
3.52%
Rev. gr., 5y
22.76%
Revenues
11.65b
+28.13%
Net income
1.87b
-25.95%
CFO
4.16b
+117.87%
Dividend
Dec 15, 20250.4 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Pembroke, Bermuda, in 1993, RenaissanceRe Holdings Ltd. (RNR) offers a variety of reinsurance and insurance solutions to clients across the United States and globally. The company's operations are divided into two primary segments. The Property division concentrates on providing catastrophe excess of loss and retrocessional reinsurance, designed to protect other insurers and reinsurers from the financial consequences of a wide array of natural and man-made calamities. These include significant events such as hurricanes, earthquakes, typhoons, tsunamis, winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism. This segment also encompasses additional property-related offerings like proportional reinsurance, property per-risk coverage, binding facilities, and regional U.S. multi-line reinsurance. The Casualty and Specialty segment underwrites a diverse portfolio of products, covering areas such as directors and officers liability, medical malpractice, professional indemnity, automobile and employer's liability, casualty clash, umbrella or excess casualty, workers' compensation, and general liability. It also addresses financial and mortgage guaranty, political risk, surety, and trade credit, alongside specialty lines like accident and health, agriculture, aviation, cyber, energy, marine, satellite, and terrorism exposures. RenaissanceRe primarily distributes its products and services via intermediaries.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||